Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 3.36% | $9.18M | €464.34B | 67.81% | 76 Outperform | |
| AstraZeneca | 2.05% | $5.60M | £210.86B | 19.89% | 80 Outperform | |
| Siemens | 1.79% | $4.88M | €199.98B | 24.44% | 74 Outperform | |
| Shell (UK) | 1.77% | $4.83M | £158.23B | 4.31% | 73 Outperform | |
| Banco Santander | 1.66% | $4.53M | €158.18B | 124.88% | 73 Outperform | |
| Roche Holding AG | 1.45% | $3.96M | CHF279.83B | 41.58% | 73 Outperform | |
| Allianz | 1.43% | $3.90M | €140.80B | 18.45% | 67 Neutral | |
| HSBC Holdings | 1.41% | $3.85M | £220.77B | 51.99% | 80 Outperform | |
| Nestlé SA | 1.35% | $3.69M | CHF185.72B | 12.00% | 71 Outperform | |
| UniCredit SpA | 1.31% | $3.58M | €114.41B | 85.13% | 75 Outperform |